The urticaria spectrum: recognition of clinical patterns can help management
- 1 May 2004
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 29 (3) , 217-221
- https://doi.org/10.1111/j.1365-2230.2004.01494.x
Abstract
Urticaria has diverse clinical presentations and causes. The implication of classifying urticaria primarily by clinical presentation rather than aetiology is that management can be focused on specific clinical problems without extensive investigations. Management pathways may involve nonpharmacological measures and drug interventions, which can be grouped into first-, second- and third-line therapies. Stronger, but potentially more risky, second- and third-line approaches may be justified for patients who do not respond to first-line therapy with antihistamines even though it may not be possible to define a specific aetiology, such as autoimmune urticaria, with confidence.Keywords
This publication has 17 references indexed in Scilit:
- Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticariaJournal of Allergy and Clinical Immunology, 2003
- Aspirin sensitivity and urticariaClinical and Experimental Dermatology, 2003
- Chronic urticariaJournal of the American Academy of Dermatology, 2002
- Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticariaBritish Journal of Dermatology, 2000
- Urticarial vasculitisCurrent Opinion in Rheumatology, 2000
- The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticariaBritish Journal of Dermatology, 1999
- Chronic idiopathic urticaria: Comparison of the clinical features of patients with and without anti-FcϵRI or anti-IgE autoantibodiesJournal of the American Academy of Dermatology, 1999
- Intravenous immunoglobulin in autoimmune chronic urticariaBritish Journal of Dermatology, 1998
- Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticariaJournal of the American Academy of Dermatology, 1993
- The effect of psoralen photochemotherapy (PUVA) on symptomatic dermographismClinical and Experimental Dermatology, 1989